The Australian Cancer Research Foundation (ACRF) has awarded the South Australian Health and Medical Research Institute (SAHMRI) $1.8 million in funding, acknowledging the promising future of cancer research in Australia.
The funding from the ACRF will be used to establish the ACRF Innovative Cancer Imaging and Therapeutics Facility housed at SAHMRI and within a new health and biomedical precinct in Adelaide that will enable the Institute’s researchers, and their collaborators, to rapidly translate basic biomedical research discoveries to novel cancer therapies.
This facility will provide cancer researchers with the tools necessary to perform cutting-edge research and will build cancer research capacity across South Australia.
SAHMRI’s Executive Director, Professor Steve Wesselingh said the Institute is thrilled with the announcement.
“We are so honoured to receive this generous award from the ACRF. We have all been touched by cancer in some shape or form, and know its devastating effects. This award will enable us to seek better treatments, cures and even ways to prevent this disease in its many manifestations.
“The ACRF Innovative Cancer Imaging and Therapeutics Facility will facilitate groundbreaking cancer research by providing investigators with access to biomedical imaging technologies, such as advanced flow cytometry, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET) and single photon emission computed tomography (SPECT).
“This facility will play a pivotal role in translating biomedical discoveries to therapies that will directly impact the health and survival of cancer patients, and we are extremely grateful to the ACRF for their support and fantastic work.”
The ACRF has been awarding major grants in excess of $1 million and up to $5 million, for building and updating research centres and laboratories, purchasing the latest technology and equipment and the establishment of national facilities in Australia, since its inception in 1984.